LAG3 and neoplasm: Lymphocyte activation gene-3 (LAG-3; CD223), a member of the immunoglobulin superfamily, is expressed on exhausted or dysfunctional T cells15–17, and it is a therapeutic target for reinvigoration of anti-tumor immunity18,19.